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STATEMENT OF THE PROBLEMS TO BE ADDRESSED BY THE G-399 PROJECT
Declining Enthusiasm
A major problem seen today is the declining enthusiasm for technology
among American college students. There are certainly many students
which are attuned to science and technology, but their numbers are
declining every year.
Declining Number of High Tech Tools
There is a declining number of high tech tools that are available to
college professors which can be used to teach students the motivation
to acquire knowledge in applied science. Sierra College's mission is
to give students skills in applying scientific tools to industry needs.
This project is to demonstrate to the students the whys and wherefores
of practical and applied science, and the creation and value of
teamwork in the solution of technical and scientific problems.
Diabetes Mellitus Treatment
Major advances have been made in the treatment of diabetes by the
fine tuning of treatment methodologies. Up until ten years ago, all
blood sugars were done in the lab monthly or less frequently with the
patient only checking his urine for sugar; this resulted in poor
control of glucose and a poorly controlled patient. Now, individual
patients can check their own blood sugars, thus achieving better
control and prolonging for a few years the complications that will
surely develop.
Knowing the exact subcellular sites of action of insulin in the body
has the potential to give basic science investigators a basis from
which a cause and cure for this disease can be approached. The goal of
this project is to create a test reagent that can be used to visualize
these subcellular sites.
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SOLUTION - THE GET AWAY SPECIAL PACKAGE FOR THE SHUTTLE
High Tech Environment
The shuttle program by itself creates a unique high tech environment
which gives "infectious enthusiasm" to students, researchers, and the
professors. The realistic demanding requirements that are the epitome
of perfection which require the patience of Job, are inherent in the
program and are part and parcel of a good business. The most rewarding
personal goals of life are usually those attained by following the
rules set down by someone else; working in the Shuttle environment
teaches the student this lesson thus preparing them for the real
business world of applied science.
Shuttle Micro Gravity Environment
The unique micro gravity environment of the Shuttle will allow the
creation of a reagent that has the possibility of elucidating the
subcellular sites of action of insulin.
If The Experiment Is Successful
If the procedure does indeed create the desired reagent for insulin,
the same procedure modified slightly, could be used to create many
other tagged entities. The list of uses for this procedure would be
endless and could extend from hormones to organisms to drugs.
DIABETES _ INSULIN
Diabetes mellitus can be defined as a disease wherein the physiologic
control mechanisms for the regulation of glucose levels by insulin are
measurably outside of defined normal levels. This is a very
complicated disease to grasp in concept since at one end of the
spectrum an individual has lost his ability to make any measurable
insulin, because of the destruction of the insulin producing cells from
the apparent effects of an auto immune phenomenon or acute pancreatitis
to the woman who only manifests the disease when she is pregnant.
The common denominator for all the diabetic states is a deficiency in
tissue response to insulin. At one end of this continuum is a no-
insulin state with a predictably no control over glucose to the other
end of the continuum where there is an excess of perfectly good insulin
that apparently is unable to influence the tissue receptors. Tissue
receptors have been counted on a cellular basis and have been found to
vary from tissue to tissue and between disease states. The exact
location of these receptors on the cell wall or other structures is
unknown.
A basic unknown is whether insulin can exert its effects from outside
the cell, i.e. near it or attached to its membrane, or does it
penetrate the cell and exert its actions from within the cell.
Possibly, it acts at different sites with different tissues or a
combination of sites. _ i
134
Autoradiography
Several techniques have been utilized in an attempt to isolate the
sites of action of items such as insulin. One of these is
autoradiography in which the test item is obtained from animals fed
radioactive materials. The test item is then radioactive and is given
to another animal. After an appropriate length of time the target
tissues are harvested and thin slices obtained for the microscope. A
photographic emulsion is placed over the tissue allowing the
radioactive material to expose the emulsion. By looking for silver
granules one can infer that the target item had appeared at that point.
This technique is capable of showing which cells absorb the test item,
but is not even close to being accurate enough to disclose the exact
subcellular site of attachment.
The Need To Visualize The Sites Of Action Of Insulin
What is clearly needed is to visualize individual insulin molecules
at their sites of action. Insulin molecules themselves do not possess
any attributes that would enable their visualization. A tag is needed
that can be placed on the insulin molecule which will enable its
localization while it is attached to the insulin receptors at its sites
of action. This tag has to satisfy a number of qualifications, two of
the more important are that it must not significantly alter the action
of insuli_ and that it must present a unique appearance on electron
microscopy to allow its reliable identification.
Ferritin
Ferritin is a large molecule having a molecular weight of
approximately 900,000 with iron atoms arranged in a characteristic
tetrad formation which is easily identified on a molecule to molecule
basis in tissues at a 160,000 magnification. Insulin with a molecular
weight of approximately 6,000 has no distinguishing features in the
electron microscope. The following figures show ferritin, both in its
pure state and after its conjugation.
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Figure i. Figure 2.
Pure Ferritin 160,000 X Ferritin-Insulin conjugate
Note: Uniform Pattern 160,000 X, Clumpped Pattern
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INSULIN TAGGING
Tagged Insulin Reagent
In summary, the insulin tagging process to be used on G-399 involves
the conjugation of insulin molecules with ferritin molecules to create
a reagent that will be used back on Earth in an attempt to elucidate
the sites of action of insulin.
During 1969 and i970, co-author of this paper, Dr. Ronald Nelson
tagged insulin with ferritin and injected it into diabetic laboratory
rats. Preliminary results were obtained, but the creation of the test
reagent was difficult because of the disparity in molecular weights
between the insulin and its iron containing tag. The photomicrographs
above clearly show that the solution of ferritin itself is very
homogeneous, while the ferritin-insulin conjugate is very lumpy, even
after considerable processing steps. It is hoped that in the
microgravity environment of space that this disparity in molecular
weights will not be a factor in the reaction that conjugates insulin
molecules with ferritin.
The conjugating process that will take place on the S_huttle and its
past history is as follows:
THE TAGGING PROCESS
The original process utilized in 1969 and 1970 for the creation of
the test reagent occurred in a glass container stirred by a standard
glass encapsulated magnet. The reaction required 24 hours at a
temperature of 4 degrees Celsius. During this time the insulin
molecules were conjugated (tagged) with the iron containing molecules
of ferritin. After conjugation, the mixture was dialysized against
normal saline to remove any remaining traces of the very active
conjugating agent difluoro-dinitro-phenyl-sulfone (DFDNDPS). Further
purification steps involving filtration and fractionation through
sephadex columns removed unconjugated insulin and overly conjugated
insulin and ferritin complexes. A major problem with the process was
the migration of the heavier iron containing ferritin to the bottom of
the reaction vessel which resulted in unwanted conjugation of ferritin
to ferritin, and at the top insulin to insulin.
The reactants will be mixed in the GAS container by being pumped
around a continuous loop for 24 hours in the microgravity environment
of the Shuttle thus avoiding the settling out of the reactants and
ensuring a uniform mixture for the entire 24 hour period. The process
in the Zpace Shuttle will end after the dialysis phase with the
reactants being stored. Further purification and separation of the
various conjugates will be done back on earth where the normal gravity
gradient will be needed for the operation of the sephadex columns.
Post flight usage of the reagent will involve its injection into the
arterial circulation of test animals that have been made diabetic.
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After various lengths of time the animals will be sacrificed and
electron microscopy used to search out the location of the ferritin
which will be presumed to be attached to insulin. A series of controls
will be utilized to make sure that the data is meaningful.
If the process proves useful for the hormone insulin, other hormones
and important proteins could be tagged with ferritin and their sites of
action determined.
Photomicrographs below show some of the original data which appears
to indicate that at least one of the sites of action are the
pinocytotic vessicles in the walls of the capillaries found in
diaphragm muscle. A major site of diabetic lesions is in large blood
vessels. A break through in protecting these structures would be most
welcome in the medical community. Little is known about the function
of insulin in glandular tissue and ferritin tagged insulin has the
potential for isolating its action in these very complex and also very
important tissues.
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Figure 3. Orientation Picture of Tissue 50,000 X
Red blood cell lower right surrounded by endothelial cells
containing pinocytotic vessicles.
(Rat pacreatatic tissue capillary)
Figure 5.
Insulin-Ferritin Conjugates within pinocytotic vessicles
(160,000 X Rat diaphragm muscle capillary endothelial cell)
137
INSULIN TAG EXPERIMENT HARDWARE
Experiment Apparatus
The hardware for the insulin tag experiment consists of 6
containers which hold the fluids required to complete the experiment, 7
solenoid controlled valves that keep the fluids separated prior to the ÷
start of the experiment, two fluid pumps for mixing and one air pump !
for fluid transfer (see figure 6).
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Figure 6. ITE Schematic
storage
Chamber I
Mixing Phase
The insulin tag experlment (ITE) begins with a temperature check
of the ferritin reservoir, mixing chamber, and DFDNDPS/DMF reservoir.
If the temperature is in the 1 to 6 degree C range, the mixing phase of
the ITE begins.
The goal of the mixing phase is to combine the DFDNDPS/DMF
solution, which is held in the DFDNDPS/DMF reservoir, with the
ferritin/ringers solution, which is contained in the ferritin
reservoir, and the insulin/deionized water/sodium carbonate solution,
which is held in the mixing chamber (see table i). All three solutions
are isolated by solenoid controlled valves_ with Teflon wetted parts.
once the proper temperature is reached, the ferritin side-0f the two
three-way valves will open, and the mixing pump will start and run for
4 minutes. At the end of the 4 minute ferritin mix, the pump will shut
down and the ferritin side of the three-way valves will close. The
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DFDNDPS/DMF side of the three way valves will then open, and the pump
will start and run for 4 minutes.
Table i: ITE Solutions
_mLum_
DMF 27 ml
DFDNDPS 961 mg
Launch LocatiQ_
DFDNDPS/DMF reservoir
ringers 69 ml
ferritin 6 g Ferritin reservoir
insulin 1.4 g
DI water i01 ml
sodium carbonate 3.4 g Mixing chamber
wash saline 500 ml
container
Wash/waste saline
The anodized 6061-T6 mixing chamber has an internal latex bladder
connected to the inside top of the chamber with a tubing clamp. The
top of the mixing chamber is penetrated by two 0.125 inch NPT 316
stainless steel compression fittings which enter through the neck of
the bladder. One of the fittings is connected to the multiplexed port
on the 3-way valve leading into the ferritin and DFDNDPS reservoirs
(see figure 6). The other fitting is connected to one side of the
mixing pump. Because DMF is a fairly active organic solvent, all of
the connections between the chambers, valves, and pumps are made with
Teflon tubing.
Wrapped and glued to the outside of the mixing chamber is a 2.5
Watt kapton insulated electric resistance heater. The microcontroller
will use the heater to maintain the temperature in the 1 to 6 degree C
range.
On the end opposite the pump and valve connections, is a single
316 stainless steel compression fitting. This fitting is connected to
a small air pump which will pressurize the mixing chamber during the
fluid transfer phase.
The ferritin and DMF/DFDNDPS reservoirs are each of the same basic
design. Each reservoir is constructed of a piece of aluminum tubing
with an aluminum end cap welded on one end, and a o-ring sealed screw
in cap on the other. Penetrating the end of each cap is a 316
stainless steel 0.125 inch NPT compression fitting. These fittings are
connected to the 3-way valves with Teflon tubing. Fastened to the wall
inside each reservoir is a flexible bladder filled with air. The air
bladders leave room for fluid expansion should the chambers freeze.
Transfer Phase
After the mixing phase is complete, the fluid in the mixing
chamber must be transferred to the dialysis chamber (see figure 6). To
accomplish this transfer, the two-way valve between the mixing chamber
and the dialysis chamber will open, and a small air pump will
pressurize the mixing chamber to a maximum of 4 psig. The increase in
pressure will force the bladder in the mixing chamber to collapse and
139
the fluid in the mixing chamber into the dialysis chamber. The two-way
valve that separates the mixing and dialysis chambers will then be
closed, and the air pump will be shut down.
Dialysis Phase
The dialysis chamber is constructed of 6061 T6 anodized aluminum.
This chamber has a pair of 316 stainless steel compression fittings
penetrating the welded end used as entry and exit ports for the
dialysis fluid. The o-ring sealed screw cap end has a single 316
stainless steel compression fitting through which the tagged insulin
will enter and exit. Inside the dialysis chamber, a single tube on the
screw cap end opens into the flexible dialysis membrane.
The dialysis chamber is heated with a 2.5 Watt Kapton insulated
electric resistance heater and has a temperature sensor for feedback to
the microcontroller.
The wash and waste saline containers are 500 ml I.V. fluid bags
contained in a composite structure box. The box is constructed of s-
glass over foam core sides, top, and bottom. A 12 Watt heater is
mounted on an aluminum plate in the bottom of the box.
The dialysis phase will last for 4 hours. During this time,
saline solution will be transferred from the wash saline storage
container, by a magnetically coupled gear pump, into the dialysis
chamber. As fresh saline is pumped into the dialysis chamber, the
waste saline is forced through an open two-way valve into the waste
saline storage container.
Storage Phase
The storage phase is the final step in the ITE. The goal of the
storage phase is to transfer the solution in the dialysis chamber into
the storage chamber. The two-way valve that separates the dialysis
chamber from the storage chamber will be opened, and the two-way valve
that allows waste saline to flow into the waste saline storage area
will remain closed. The wash saline pump will transfer approximately
i00 ml of wash saline into the dialysis chamber. This will force the
solution contained in the dialysis tubing into the storage container.
Finally the storage container two-way valve will be closed.
The storage container is a 250 ml polypropylene chemical storage
bottle with a stainless steel tube penetrating the lid. The storage
container is connected to a stainless steel "T" fitting which is
connected between the dialysis chamber and the mixing chamber. An
isolation valve prevents fluid from entering the storage container
during the fluid transfer phase.
Safety Considerations
The fluid pumps used in the ITE are magnetically coupled, gear
driven. The fluid pumps can generate a maximum of 49 psig in the
unlikely event of an overpressure condition. An overpressure condition
may occur if a valve failed to open and the pump was switched on. The
magnetic coupling on the pump disengages within 0.5 seconds during an
overpressure condition and the pressure drops to 0 psig. The ITE has
been proof pressure tested to twice the maximum design pressure (i00
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psig). The pump housing is 316 stainless steel and the internal gears
are Delrin.
Because the ITE uses a flammable organic solvent, the entire
experiment must be triple contained. The ITE is fully contained in a
0.160 inch 6061-T6 aluminum containment vessel. The containment vessel
will be purged with gaseous nitrogen prior to the sealing of the GAS
canister.
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